168 related articles for article (PubMed ID: 37937047)
1. Brief overview of immunosuppression and its side effects after liver transplantation.
Rabiee A; Girone G; Davis JPE
Clin Liver Dis (Hoboken); 2023 Jun; 21(6):160-164. PubMed ID: 37937047
[TBL] [Abstract][Full Text] [Related]
2. Review on immunosuppression in liver transplantation.
Moini M; Schilsky ML; Tichy EM
World J Hepatol; 2015 Jun; 7(10):1355-68. PubMed ID: 26052381
[TBL] [Abstract][Full Text] [Related]
3. [Update: Immunosuppression in organ transplantation].
Kniepeiss D; Rosenkranz AR; Fickert P; Schemmer P
Dtsch Med Wochenschr; 2022 Sep; 147(18):1199-1212. PubMed ID: 36070738
[TBL] [Abstract][Full Text] [Related]
4. [What's new in immunosuppression for renal transplantation?].
Milicevic M; Krzesinski JM; Squifflet JP
Rev Med Liege; 2007; 62(5-6):371-6. PubMed ID: 17725209
[TBL] [Abstract][Full Text] [Related]
5. Withdrawal of immunosuppression in liver transplantation and the mechanism of tolerance.
Zhang CX; Wen PH; Sun YL
Hepatobiliary Pancreat Dis Int; 2015 Oct; 14(5):470-6. PubMed ID: 26459722
[TBL] [Abstract][Full Text] [Related]
6. Immunosuppression in liver transplantation.
Mukherjee S; Botha JF; Mukherjee U
Curr Drug Targets; 2009 Jun; 10(6):557-74. PubMed ID: 19519358
[TBL] [Abstract][Full Text] [Related]
7. Maxillofacial considerations in orthotopic liver transplantation.
Ziccardi VB; Abubaker AO; Sotereanos GC; Patterson GT
Oral Surg Oral Med Oral Pathol; 1991 Jan; 71(1):21-6. PubMed ID: 1704494
[TBL] [Abstract][Full Text] [Related]
8. Cell therapeutic approaches to immunosuppression after clinical kidney transplantation.
Morath C; Schmitt A; Kälble F; Zeier M; Schmitt M; Sandra-Petrescu F; Opelz G; Terness P; Schaier M; Kleist C
Pediatr Nephrol; 2018 Feb; 33(2):199-213. PubMed ID: 28229281
[TBL] [Abstract][Full Text] [Related]
9. Early immunosuppression withdrawal after living donor liver transplantation and donor stem cell infusion.
Donckier V; Troisi R; Le Moine A; Toungouz M; Ricciardi S; Colle I; Van Vlierberghe H; Craciun L; Libin M; Praet M; Noens L; Stordeur P; Andrien M; Lambermont M; Gelin M; Bourgeois N; Adler M; de Hemptinne B; Goldman M
Liver Transpl; 2006 Oct; 12(10):1523-8. PubMed ID: 17004249
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppression induction with rabbit anti-thymocyte globulin with or without rituximab in 1000 liver transplant patients with long-term follow-up.
Mangus RS; Fridell JA; Vianna RM; Kwo PY; Chen J; Tector AJ
Liver Transpl; 2012 Jul; 18(7):786-95. PubMed ID: 22237953
[TBL] [Abstract][Full Text] [Related]
11. [Pneumococcal vaccination after heart and liver transplantation. Immune responses in immunosuppressed patients and in healthy controls].
Dengler TJ; Strnad N; Zimmermann R; Allers C; Markus BH; Nessen SV; Kübler W; Zielen S
Dtsch Med Wochenschr; 1996 Dec; 121(49):1519-25. PubMed ID: 8998919
[TBL] [Abstract][Full Text] [Related]
12. Comparison of steroid-free immunosuppression and standard immunosuppression for liver transplant patients with hepatocellular carcinoma.
Xing T; Huang L; Yu Z; Zhong L; Wang S; Peng Z
PLoS One; 2013; 8(8):e71251. PubMed ID: 23940730
[TBL] [Abstract][Full Text] [Related]
13. Trial of complete weaning from immunosuppression for liver transplant recipients: factors predictive of tolerance.
de la Garza RG; Sarobe P; Merino J; Lasarte JJ; D'Avola D; Belsue V; Delgado JA; Silva L; Iñarrairaegui M; Sangro B; Sola JJ; Pardo F; Quiroga J; Herrero JI
Liver Transpl; 2013 Sep; 19(9):937-44. PubMed ID: 23784747
[TBL] [Abstract][Full Text] [Related]
14. Clinical pancreas and islet transplantation. Part 1: registry statistics and an overview.
Sutherland DE
Prim Care; 1983 Dec; 10(4):707-16. PubMed ID: 6425881
[TBL] [Abstract][Full Text] [Related]
15. Adverse effects of immunosuppression after liver transplantation.
Noble J; Terrec F; Malvezzi P; Rostaing L
Best Pract Res Clin Gastroenterol; 2021; 54-55():101762. PubMed ID: 34874845
[TBL] [Abstract][Full Text] [Related]
16. A new side effect of immunosuppression: high incidence of hearing impairment after liver transplantation.
Rifai K; Kirchner GI; Bahr MJ; Cantz T; Rosenau J; Nashan B; Klempnauer JL; Manns MP; Strassburg CP
Liver Transpl; 2006 Mar; 12(3):411-5. PubMed ID: 16456830
[TBL] [Abstract][Full Text] [Related]
17. Immunosuppression after liver transplantation for primary sclerosing cholangitis influences activity of inflammatory bowel disease.
Jørgensen KK; Lindström L; Cvancarova M; Karlsen TH; Castedal M; Friman S; Schrumpf E; Foss A; Isoniemi H; Nordin A; Holte K; Rasmussen A; Bergquist A; Vatn MH; Boberg KM
Clin Gastroenterol Hepatol; 2013 May; 11(5):517-23. PubMed ID: 23333218
[TBL] [Abstract][Full Text] [Related]
18. Immunosuppression minimization vs. complete drug withdrawal in liver transplantation.
Londoño MC; Rimola A; O'Grady J; Sanchez-Fueyo A
J Hepatol; 2013 Oct; 59(4):872-9. PubMed ID: 23578883
[TBL] [Abstract][Full Text] [Related]
19. Induction immunosuppression in adults undergoing liver transplantation: a network meta-analysis.
Best LM; Leung J; Freeman SC; Sutton AJ; Cooper NJ; Milne EJ; Cowlin M; Payne A; Walshaw D; Thorburn D; Pavlov CS; Davidson BR; Tsochatzis E; Williams NR; Gurusamy KS
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD013203. PubMed ID: 31978255
[TBL] [Abstract][Full Text] [Related]
20. Effects of re-augmenting maintenance immunosuppression on post-transplant donor-specific HLA antibodies in liver transplantation.
Tokodai K; Miyagi S; Nakanishi W; Fujio A; Kashiwadate T; Goto M; Unno M; Kamei T
Transpl Immunol; 2020 Dec; 63():101334. PubMed ID: 32919028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
